Groups | Mean ± SD | 95% CI | CV% |
---|---|---|---|
CAT (U/mg) | |||
Control | 207.2 ± 22.5 | 196.4 to 219.3 | 10.9 |
STHMVO | 206.8 ± 19.3 | 194.5 to 219.0 | 9.3 |
L-RHMVO | 148.9 ± 15.5 * | 139.1 to 158.7 | 10.4 |
H-RHMVO | 140.5 ± 12.4 ** | 132.6 to 148.4 | 8.8 |
SOD (U/mg) | |||
Control | 29.3 ± 1.5 | 28.4 to 30.2 | 4.9 |
STHMVO | 29.9 ± 1.4 | 28.0 to 30.9 | 4.6 |
L-RHMVO | 13.3 ± 1.3 * | 12.5 to 14.1 | 9.5 |
H-RHMVO | 7.7 ± 0.6 * | 7.3 to 8.1 | 7.2 |
GPx (U/mg) | |||
Control | 34.6 ± 1.4 | 33.8 to 35.5 | 3.9 |
STHMVO | 33.8 ± 1.3 | 33.0 to 34.6 | 3.7 |
L-RHMVO | 19.6 ± 1.5 * | 18.7 to 20.5 | 7.4 |
H-RHMVO | 8.3 ± 0.5 * | 7.9 to 8.6 | 6.1 |
MDA (nmol/g) | |||
Control | 15.5 ± 1.6 | 14.4 to 16.5 | 10.5 |
STHMVO | 15.0 ± 1.4 | 14.2 to 15.9 | 9.1 |
L-RHMVO | 39.5 ± 1·9 * | 38.3 to 40.6 | 4.7 |
H-RHMVO | 42.5 ± 5.2 ** | 39.2 to 45.8 | 12.2 |